Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Polyprenol reductase (SRD5A3), resident on the endoplasmic r...
| Class:Id | Summation:4420009 |
|---|---|
| _displayName | Polyprenol reductase (SRD5A3), resident on the endoplasmic r... |
| _timestamp | 2013-10-25 12:32:41 |
| created | [InstanceEdit:4420019] Jassal, B, 2013-08-29 |
| modified | [InstanceEdit:4420232] Jassal, B, 2013-08-30 [InstanceEdit:4755549] Jassal, B, 2013-10-25 |
| text | Polyprenol reductase (SRD5A3), resident on the endoplasmic reticulum membrane, mediates the reduction of the alpha-isoprene unit of polyprenol (pPNOL) to form dolichol (DCHOL) in a NADPH-dependent manner (Cantagrel et al. 2010). Defects in SRD5A3 cause congenital disorder of glycosylation 1q (SRD5A3-CDG, CDG1Q; MIM:612379), a neurodevelopmental disorder characterised by under-glycosylated serum glycoproteins resulting in nervous system development, psychomotor retardation, hypotonia, coagulation disorders and immunodeficiency (Cantagrel et al. 2010, Kasapkara et al. 2012). Defects in SRD5A3 can also cause Kahrizi syndrome (KHRZ; MIM:612713), a neurodevelopmental disorder characterised by mental retardation, cataracts, coloboma, kyphosis, and coarse facial features (Kahrizi et al. 2011). |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Polyprenol reductase (SRD5A3), resident on the endoplasmic r... (4420009)
